Endophenotypes in Schizophrenia for the Perinatal Period: Criteria for Validation.
Endophenotypes are disease-associated phenotypes that are thought to reflect the neurobiological or other mechanisms that underlie the more overt symptoms of a psychiatric illness. Endophenotypes have been critical in understanding the genetics, neurobiology, and treatment of schizophrenia. Because psychiatric illnesses have multiple causes, including both genetic and nongenetic risk factors, an endophenotype linked to one of the mechanisms may be expressed more frequently than the disease itself. However, in schizophrenia research, endophenotypes have almost exclusively been studied in older adolescents or adults who have entered or passed through the age of risk for the disorder. Yet, schizophrenia is a neurodevelopmental disorder where prenatal development starts a cascade of brain changes across the lifespan. Endophenotypes have only minimally been utilized to explore the perinatal development of vulnerability. One major impediment to the development of perinatally-useful endophenotypes has been the established validity criteria. For example, the criterion that the endophenotype be more frequently present in those with disease than those without is difficult to demonstrate when there can be a decades-long period between endophenotype measurement and the age of greatest risk for onset of the disorder. This article proposes changes to the endophenotype validity criteria appropriate to perinatal research and reviews how application of these modified criteria helped identify a perinatally-usable phenotype of risk for schizophrenia, P50 sensory gating, which was then used to propose a novel perinatal primary prevention intervention.
Department of Psychiatry, University of Colorado Denver, Aurora, CO randy.ross@UCDenver.edu.
Randal G
RG
Ross
Department of Psychiatry, University of Colorado Denver, Aurora, CO.
Robert
R
Freedman
D015415:Biomarkers; D058068:Endophenotypes; D005071:Evoked Potentials / Q000502:physiology*; D006801:Humans; D007223:Infant; D012559:Schizophrenia / Q000175:diagnosis* / Q000503:physiopathology; D055139:Sensory Gating / Q000502:physiology*; D054928:Validation Studies as Topic
D015415:Biomarkers
biological markers; endophenotype; infant; schizophrenia; sensory gating